Profil
Frederick W.
Kyle is currently the Chairman at BioRexis Pharmaceutical Corp.
and a Director at Suvoda LLC.
Previously, he was a Director at AVANT Immunotherapeutics, Inc. and the President-Worldwide Operations at Smithkline Beecham Plc.
Postes actifs de Frederick W. Kyle
| Sociétés | Poste | Début |
|---|---|---|
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures and provides novel protein and peptide drugs | Président | - |
Suvoda LLC
Suvoda LLC Information Technology ServicesTechnology Services Provides clinical trial management software and services | Directeur/Membre du Conseil | - |
Anciens postes connus de Frederick W. Kyle
| Sociétés | Poste | Fin |
|---|---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Directeur des opérations | - |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures and provides novel protein and peptide drugs | Health Technology |
Suvoda LLC
Suvoda LLC Information Technology ServicesTechnology Services Provides clinical trial management software and services | Technology Services |
















